Robert Dempsey

Robert Dempsey serves as the Chief Executive Officer and President of AsclepiX Therapeutics, Inc. since March 2021. Currently, Dempsey holds multiple leadership positions, including Chair of the Board of Directors at TearSolutions Inc. and iVeena, as well as Board Director at Neurotech Pharmaceuticals, Inc. and Glauconix Biosciences, Inc. Dempsey co-founded the Holland Foundation For Sight Restoration and previously held executive roles at TearClear, Shire, and Bausch + Lomb, with a notable focus on ophthalmics and eye care. Dempsey has an MBA and a Bachelor's degree in Healthcare Marketing from Northeastern University.